GSK is acquiring lung cancer biotech Nuvalent in its biggest deal in over a decade
Cris Tolomia
·
2026-06-09
·
via Quartz
The all-cash deal, GSK's largest in more than a decade, gives the British drugmaker two late-stage lung cance…
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
